Sergey Zakharov Selected Research

Methanol (Carbinol)

10/2021	Cognitive changes after methanol exposure: Longitudinal perspective.
3/2021	Efficiency of 123I-ioflupane SPECT as the marker of basal ganglia damage in acute methanol poisoning: 6-year prospective study.
1/2021	Estimation of long-term costs of postacute care in survivors of the methanol poisoning outbreak.
12/2020	Formaldehyde Reacts with Amino Acids and Peptides with a Potential Role in Acute Methanol Intoxication.
1/2020	Peripheral polyneuropathy after acute methanol poisoning: Six-year prospective cohort study.
1/2020	The impact of co-morbidities on a 6-year survival after methanol mass poisoning outbreak: possible role of metabolic formaldehyde.
1/2020	Health-related quality of life determinants in survivors of a mass methanol poisoning outbreak: six-year prospective cohort study.
1/2020	MRI-based brain volumetry and retinal optical coherence tomography as the biomarkers of outcome in acute methanol poisoning.
12/2019	Consensus statements on the approach to patients in a methanol poisoning outbreak.
1/2019	Clinical and genetic determinants of chronic visual pathway changes after methanol - induced optic neuropathy: four-year follow-up study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergey Zakharov Research Topics

Disease

36	Poisoning 10/2021 - 08/2012
5	Inflammation (Inflammations) 01/2020 - 01/2016
3	Neuroinflammatory Diseases 01/2020 - 04/2017
3	Optic Nerve Diseases (Optic Neuropathy) 01/2019 - 01/2018
3	Acidosis 12/2018 - 12/2014
2	Neoplasms (Cancer) 12/2020 - 01/2020
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2019 - 12/2018
2	Disease Progression 01/2017 - 02/2015
2	Coma (Comas) 05/2015 - 12/2014
2	Heart Failure 05/2013 - 02/2007
1	Cognitive Dysfunction 10/2021
1	Necrosis 12/2020
1	Vision Disorders (Hemeralopia) 12/2020
1	Burns 07/2020
1	Alcoholism (Alcohol Abuse) 01/2020
1	Ganglion Cysts (Ganglion) 01/2020
1	Polyneuropathies (Polyneuropathy) 01/2020
1	Memory Disorders (Memory Loss) 01/2019
1	Hypotension (Low Blood Pressure) 12/2018
1	Critical Illness (Critically Ill) 12/2018
1	Lactic Acidosis 12/2018
1	Cerebral Hemorrhage 11/2016
1	Wounds and Injuries (Trauma) 01/2016
1	Hypoalbuminemia 01/2016
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 01/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 02/2015
1	Communicable Diseases (Infectious Diseases) 06/2014
1	Occupational Asthma 04/2014
1	Myocardial Infarction 05/2013
1	Tics (Tic) 08/2012
1	Hypertension (High Blood Pressure) 02/2007
1	Ischemia 02/2007

Drug/Important Bio-Agent (IBA)

35	Methanol (Carbinol)IBA 10/2021 - 07/2014
11	Ethanol (Ethyl Alcohol)IBA 01/2020 - 12/2014
6	AntidotesIBA 01/2020 - 12/2014
5	Fomepizole (Antizol)FDA LinkGeneric 01/2020 - 12/2014
5	formic acid (formate)IBA 12/2018 - 07/2014
3	LeukotrienesIBA 01/2020 - 04/2017
2	CreatinineIBA 03/2021 - 01/2016
2	Lactic Acid (Lactate)FDA LinkGeneric 03/2021 - 12/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2017
2	Retinaldehyde (Retinal)IBA 01/2020 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
2	Biological ProductsIBA 01/2016 - 01/2016
2	EnzymesIBA 01/2016 - 02/2015
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 07/2015 - 02/2015
1	ioflupaneIBA 03/2021
1	Glucose (Dextrose)FDA LinkGeneric 03/2021
1	Nicotine FDA Link 07/2020
1	Leukotriene C4IBA 01/2020
1	Formaldehyde (Formol)FDA Link 01/2020
1	Nucleic AcidsIBA 01/2020
1	Leukotriene B4IBA 01/2020
1	LipidsIBA 01/2020
1	Leukotriene E4IBA 01/2020
1	Leukotriene D4IBA 01/2020
1	Apolipoprotein E4IBA 01/2019
1	Interleukin-4 (Interleukin 4)IBA 12/2018
1	LipoxinsIBA 12/2018
1	Interleukin-13IBA 12/2018
1	lipoxin A4IBA 12/2018
1	InterleukinsIBA 12/2018
1	Interleukin-9 (Interleukin 9)IBA 12/2018
1	Interleukin-10 (Interleukin 10)IBA 12/2018
1	Interleukin-5 (Interleukin 5)IBA 12/2018
1	lipoxin B4IBA 12/2018
1	Membrane LipidsIBA 10/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	ferric oxide (iron oxide)IBA 02/2016
1	AerosolsIBA 02/2016
1	ElectrolytesIBA 01/2016
1	Urea (Carbamide)FDA LinkGeneric 01/2016
1	mancozebIBA 01/2016
1	Hydroxocobalamin FDA Link 09/2015
1	sodium thiosulfate FDA Link 09/2015
1	Cyanides (Isocyanides)IBA 09/2015
1	microsomal ethanol-oxidizing system (MEOS)IBA 02/2015
1	Bicarbonates (Hydrogen Carbonate)IBA 01/2015
1	Dialysis SolutionsIBA 07/2014
1	Pharmaceutical PreparationsIBA 06/2014
1	AllergensIBA 04/2014
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 05/2013
1	salicylhydroxamic acid (SHAM)IBA 05/2013
1	Insulin ReceptorIBA 02/2007
1	CationsIBA 02/2007
1	beta Adrenergic ReceptorsIBA 02/2007

Therapy/Procedure

7	Renal Dialysis (Hemodialysis) 01/2020 - 07/2014
5	Continuous Renal Replacement Therapy 01/2020 - 07/2014
2	Treatment Delay 01/2017 - 01/2016
1	Subacute Care 01/2021
1	Hemodiafiltration 07/2014
1	Medication Errors (Medication Error) 08/2012